11.9 C
New York
Wednesday, March 22, 2023

The Question Is Whether To Buy Or Not To Buy PaxMedica Inc. (NASDAQ: PXMD)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for PaxMedica Inc. (PXMD) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.05, or 2.19%, to $2.33. The PaxMedica Inc. has recorded 15,577 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that PaxMedica Releases 2022 Shareholder Letter.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Stocks Info

PaxMedica Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $2.28 and fluctuated between $2.3700 as its day high and $1.9300 as its day low. The current market capitalization of PaxMedica Inc. is $25.42M. A total of 1.91 million shares were traded on the day, compared to an average of 957.17K shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, PXMD has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 4 BUYs and 0 SELLs from insiders. Insiders purchased 376,583 shares during that period but sold 0.

In the most recent transaction, Weisman Howard J. sold 3,495 shares of PXMD for 1.44 per share on Mar 09. After the transaction, the Chief Executive Officer now owns 541,633 company shares. In a previous transaction on Mar 09, Rome Zachary sold 3,371 shares at 1.44 per share. PXMD shares that Chief Operating Officer owns now total 288,452.

Among the insiders who sold shares, Derby Michael disposed of 2,143 shares on Mar 09 at a per-share price of $1.43. This resulted in the Executive Chairman holding 324,430 shares of PXMD after the transaction. In another insider transaction, LaRochelle Karen sold 335 shares at $1.48 per share on Mar 09. Company shares held by the Director now total 42,415.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, PXMD has a high of $10.48 and a low of $1.36.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles